JP2014528576A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014528576A5 JP2014528576A5 JP2014533428A JP2014533428A JP2014528576A5 JP 2014528576 A5 JP2014528576 A5 JP 2014528576A5 JP 2014533428 A JP2014533428 A JP 2014533428A JP 2014533428 A JP2014533428 A JP 2014533428A JP 2014528576 A5 JP2014528576 A5 JP 2014528576A5
- Authority
- JP
- Japan
- Prior art keywords
- individual
- group
- risk
- information corresponding
- biomarkers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000090 biomarker Substances 0.000 claims 27
- 238000000034 method Methods 0.000 claims 27
- 230000002526 effect on cardiovascular system Effects 0.000 claims 20
- 102100026802 72 kDa type IV collagenase Human genes 0.000 claims 5
- 101710151806 72 kDa type IV collagenase Proteins 0.000 claims 5
- 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 claims 5
- 102100023701 C-C motif chemokine 18 Human genes 0.000 claims 5
- 108010028776 Complement C7 Proteins 0.000 claims 5
- 102100024336 Complement component C7 Human genes 0.000 claims 5
- 102100040898 Growth/differentiation factor 11 Human genes 0.000 claims 5
- 101710194452 Growth/differentiation factor 11 Proteins 0.000 claims 5
- 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 claims 5
- 108010091628 alpha 1-Antichymotrypsin Proteins 0.000 claims 5
- 102000003801 alpha-2-Antiplasmin Human genes 0.000 claims 5
- 108090000183 alpha-2-Antiplasmin Proteins 0.000 claims 5
- 239000012472 biological sample Substances 0.000 claims 5
- 238000004458 analytical method Methods 0.000 claims 4
- 210000004369 blood Anatomy 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 238000004590 computer program Methods 0.000 claims 4
- 238000003384 imaging method Methods 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims 3
- 108091023037 Aptamer Proteins 0.000 claims 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 2
- 230000017531 blood circulation Effects 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 238000002592 echocardiography Methods 0.000 claims 2
- 230000002068 genetic effect Effects 0.000 claims 2
- 239000002853 nucleic acid probe Substances 0.000 claims 2
- 210000002381 plasma Anatomy 0.000 claims 2
- 238000012502 risk assessment Methods 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 238000012360 testing method Methods 0.000 claims 2
- 210000002700 urine Anatomy 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 208000031481 Pathologic Constriction Diseases 0.000 claims 1
- 238000002583 angiography Methods 0.000 claims 1
- 210000003423 ankle Anatomy 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 238000010968 computed tomography angiography Methods 0.000 claims 1
- 210000004351 coronary vessel Anatomy 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000014509 gene expression Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 238000009533 lab test Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 230000002107 myocardial effect Effects 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 102000054765 polymorphisms of proteins Human genes 0.000 claims 1
- 230000004044 response Effects 0.000 claims 1
- 230000000250 revascularization Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 235000021003 saturated fats Nutrition 0.000 claims 1
- 230000000391 smoking effect Effects 0.000 claims 1
- 230000036262 stenosis Effects 0.000 claims 1
- 208000037804 stenosis Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 238000002604 ultrasonography Methods 0.000 claims 1
- 229940124549 vasodilator Drugs 0.000 claims 1
- 239000003071 vasodilator agent Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019193933A JP6917432B2 (ja) | 2011-09-30 | 2019-10-25 | 心血管系リスクイベントの予測およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161541828P | 2011-09-30 | 2011-09-30 | |
| US61/541,828 | 2011-09-30 | ||
| PCT/US2012/058060 WO2013049674A1 (en) | 2011-09-30 | 2012-09-28 | Cardiovascular risk event prediction and uses thereof |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018103211A Division JP6546318B2 (ja) | 2011-09-30 | 2018-05-30 | 心血管系リスクイベントの予測およびその使用 |
| JP2019193933A Division JP6917432B2 (ja) | 2011-09-30 | 2019-10-25 | 心血管系リスクイベントの予測およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014528576A JP2014528576A (ja) | 2014-10-27 |
| JP2014528576A5 true JP2014528576A5 (https=) | 2015-11-12 |
| JP6652781B2 JP6652781B2 (ja) | 2020-02-26 |
Family
ID=47993164
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014533428A Active JP6652781B2 (ja) | 2011-09-30 | 2012-09-28 | 心血管系リスクイベントの予測およびその使用 |
| JP2018103211A Active JP6546318B2 (ja) | 2011-09-30 | 2018-05-30 | 心血管系リスクイベントの予測およびその使用 |
| JP2019193933A Active JP6917432B2 (ja) | 2011-09-30 | 2019-10-25 | 心血管系リスクイベントの予測およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018103211A Active JP6546318B2 (ja) | 2011-09-30 | 2018-05-30 | 心血管系リスクイベントの予測およびその使用 |
| JP2019193933A Active JP6917432B2 (ja) | 2011-09-30 | 2019-10-25 | 心血管系リスクイベントの予測およびその使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20130085079A1 (https=) |
| EP (1) | EP2761289B1 (https=) |
| JP (3) | JP6652781B2 (https=) |
| KR (2) | KR102248900B1 (https=) |
| CN (4) | CN103959060B (https=) |
| AU (1) | AU2013202112B9 (https=) |
| BR (2) | BR122019023720B1 (https=) |
| CA (2) | CA2847903C (https=) |
| ES (1) | ES2777002T3 (https=) |
| IL (1) | IL231387A (https=) |
| IN (1) | IN2014CN01970A (https=) |
| MX (2) | MX373248B (https=) |
| RU (1) | RU2651708C2 (https=) |
| SG (3) | SG10201607331WA (https=) |
| WO (1) | WO2013049674A1 (https=) |
| ZA (1) | ZA201401778B (https=) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012006632A2 (en) | 2010-07-09 | 2012-01-12 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| US20130171649A1 (en) * | 2010-06-07 | 2013-07-04 | Manuel Mayr | Methods and means for predicting or diagnosing diabetes or cardiovascular disorders based on micro rna |
| SG187045A1 (en) | 2010-08-13 | 2013-02-28 | Somalogic Inc | Pancreatic cancer biomarkers and uses thereof |
| AU2012225273B2 (en) | 2011-03-10 | 2016-10-13 | Somalogic, Inc. | Aptamers for Clostridium difficile diagnostics |
| MX373248B (es) * | 2011-09-30 | 2020-05-11 | Somalogic Operating Co Inc | Prediccion de riesgo de evento cardiovascular y usos del mismo. |
| WO2013113012A2 (en) | 2012-01-27 | 2013-08-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for profiling and quantitating cell-free rna |
| US20160289762A1 (en) | 2012-01-27 | 2016-10-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for profiliing and quantitating cell-free rna |
| JP6198047B2 (ja) * | 2013-08-02 | 2017-09-20 | 国立大学法人岐阜大学 | 冠動脈疾患の検査キット |
| JP6506768B2 (ja) | 2013-09-24 | 2019-04-24 | ソマロジック・インコーポレーテッド | 多重アプタマー標的の検出 |
| WO2015140317A1 (en) * | 2014-03-21 | 2015-09-24 | Sanofi | New markers for the assessment of the risk for development of a cardiovascular disorder |
| US20170102396A1 (en) * | 2014-06-05 | 2017-04-13 | Sanofi-Aventis Deutschland Gmbh | New markers for the assessment of an increased risk for mortality |
| ES2792227T3 (es) * | 2014-09-26 | 2020-11-10 | Somalogic Inc | Predicción de evento de riesgo cardiovascular y usos de la misma |
| WO2016123163A2 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
| CN108291330A (zh) * | 2015-07-10 | 2018-07-17 | 西弗吉尼亚大学 | 卒中和卒中严重性的标志物 |
| RU2602451C1 (ru) * | 2015-08-28 | 2016-11-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого" Министерства здравоохранения Российской Федерации | Способ диагностики генетической предрасположенности к развитию ишемического инсульта у больных с фибрилляцией предсердий |
| CN116008563B (zh) | 2016-02-08 | 2025-12-19 | 私募蛋白质体操作有限公司 | 非酒精性脂肪肝疾病(nafld)和非酒精性脂肪性肝炎(nash)生物标记及其用途 |
| US20190071795A1 (en) * | 2016-03-09 | 2019-03-07 | Molecular Stethoscope, Inc. | Methods and systems for detecting tissue conditions |
| AU2017245701A1 (en) * | 2016-04-06 | 2018-08-23 | Société des Produits Nestlé S.A. | Biomarkers for predicting degree of weight loss |
| EP3440995B1 (en) * | 2016-04-15 | 2021-06-16 | Omron Corporation | Biological information analysis device, system, and program |
| CN105907857A (zh) * | 2016-04-29 | 2016-08-31 | 天津脉络生物科技有限公司 | 一种用于动脉血栓的分子标记物和试剂及其应用 |
| WO2017214684A1 (en) * | 2016-06-17 | 2017-12-21 | Adelaide Research & Innovation Pty Ltd | Methods and products for identifying conditions associated with cardiac fibrotic remodelling |
| ES2817087T3 (es) * | 2016-08-04 | 2021-04-06 | Hoffmann La Roche | ESM-1 (endocan) circulante en la evaluación de la fibrilación auricular |
| US11079394B2 (en) * | 2017-07-25 | 2021-08-03 | Vanderbilt University | Detection of angiopoietin-2 and thrombospondin-2 in connection with diagnosing acute heart failure |
| BR112020011454A2 (pt) * | 2017-12-13 | 2021-02-09 | F. Hoffmann-La Roche Ag | métodos para prever o risco de acidente vascular, para prever o risco de acidente vascular cerebral e para aprimorar a precisão da previsão e usos do (i) biomarcador ang-2 e/ou do biomarcador igfbp7 |
| RU2685859C1 (ru) * | 2018-07-04 | 2019-04-23 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ прогнозирования риска развития ишемического инсульта |
| CN109192250B (zh) * | 2018-08-01 | 2021-12-07 | 华东理工大学 | 一种多相催化中克服表面物种快速迁移的加速模拟方法 |
| KR20210044216A (ko) * | 2018-08-10 | 2021-04-22 | 에프. 호프만-라 로슈 아게 | 심방세동-관련 뇌졸중 평가를 위한 ces-2 (카르복실에스테라제-2) |
| WO2020037244A1 (en) * | 2018-08-17 | 2020-02-20 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Use of machine learning models for prediction of clinical outcomes |
| WO2020039001A1 (en) * | 2018-08-22 | 2020-02-27 | Roche Diagnostics Gmbh | Circulating spon-1 (spondin-1) in the assessment of atrial fibrillation |
| EP3874275B1 (en) * | 2018-10-31 | 2022-11-23 | Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) | Biomarkers of subclinical atherosclerosis |
| KR102125053B1 (ko) * | 2018-12-14 | 2020-06-19 | 가톨릭대학교 산학협력단 | 심혈관계 질환의 검출용 조성물 및 이를 포함하는 키트 |
| GB2612911B (en) | 2019-02-14 | 2023-11-22 | Mirvie Inc | Methods and systems for determining a pregnancy-related state of a subject |
| GB201906052D0 (en) | 2019-04-30 | 2019-06-12 | Int Centre For Genetic Engineering And Biotechnology | Proteins with cardioprotective activity |
| US11030743B2 (en) * | 2019-05-16 | 2021-06-08 | Tencent America LLC | System and method for coronary calcium deposits detection and labeling |
| AU2020343243A1 (en) * | 2019-09-03 | 2022-03-10 | Somalogic Operating Co., Inc. | Cardiovascular risk event prediction and uses thereof |
| JP7510649B2 (ja) * | 2019-11-06 | 2024-07-04 | 国立大学法人 香川大学 | 心不全マーカー |
| US20230170050A1 (en) * | 2020-04-17 | 2023-06-01 | Phenomic Ai | System and method for profiling antibodies with high-content screening (hcs) |
| US10902955B1 (en) * | 2020-05-01 | 2021-01-26 | Georgetown University | Detecting COVID-19 using surrogates |
| TW202201007A (zh) * | 2020-05-19 | 2022-01-01 | 美商獵鷹生科有限責任公司 | 以灌注不足為特徵的病症的檢測和治療 |
| FI130424B (en) * | 2020-06-18 | 2023-08-23 | Nightingale Health Oy | Procedure for determining whether a subject has a disease or condition or whether the subject is at risk of developing a disease or condition |
| US20230393146A1 (en) * | 2020-10-20 | 2023-12-07 | Somalogic Operating Co., Inc. | Cardiovascular Event Risk Prediction |
| RU2750716C1 (ru) * | 2020-11-23 | 2021-07-01 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр кардиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ кардиологии" Минздрава России) | Способ прогнозирования сердечно-сосудистых осложнений у больных низкого или умеренного сердечно-сосудистого риска путем оценки их психологического статуса |
| US20240060998A1 (en) * | 2021-02-01 | 2024-02-22 | Medtronic, Inc. | A method to identify lvad patients with elevated levels of blood activation using coupon tests |
| RU2757752C1 (ru) * | 2021-04-26 | 2021-10-21 | Общество с ограниченной ответственностью "Медицинская Технологическая Компания" (ООО МТК) | Способ определения индивидуального профиля факторов суммарного сердечно-сосудистого риска у пациента трудоспособного возраста |
| US20250248660A1 (en) * | 2021-08-26 | 2025-08-07 | 3P Healthcare Pty Ltd | System and method for cardiovascular health assessment and risk management |
| US12412661B2 (en) | 2021-11-25 | 2025-09-09 | Samsung Electronics Co., Ltd. | Electronic device and method of providing health guideline using the same |
| EP4230233A1 (en) * | 2022-02-22 | 2023-08-23 | mimiX Biotherapeutics Sàrl | Method for producing tissue constructs |
| CA3248538A1 (en) * | 2022-04-15 | 2023-10-19 | Memorial Hospital For Cancer And Allied Diseases | Multi-modal machine learning to determine risk stratification |
| CN115932276B (zh) * | 2022-12-07 | 2025-09-02 | 首都医科大学附属北京安贞医院 | 一种检测生物标志物的产品在制备急性心肌梗死或其并发症的诊断的产品中用途 |
| EP4698047A2 (en) * | 2023-04-24 | 2026-02-25 | Google LLC | Deep learning-based photoplethysmography model for cardiovascular risk prediction |
| WO2026017134A1 (en) * | 2024-07-19 | 2026-01-22 | The University Of Hong Kong | Methods and systems to determine early acute ischemic stroke (es) in acute ischemic stroke (ais) patients |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5660985A (en) * | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
| US20030144476A1 (en) * | 2000-03-06 | 2003-07-31 | Pankaj Agarwal | Novel compounds |
| US20030224501A1 (en) * | 2000-03-17 | 2003-12-04 | Young Paul E. | Bone morphogenic protein polynucleotides, polypeptides, and antibodies |
| US6930085B2 (en) * | 2002-04-05 | 2005-08-16 | The Regents Of The University Of California | G-type peptides to ameliorate atherosclerosis |
| DK3072978T3 (en) * | 2002-05-09 | 2018-09-17 | Brigham & Womens Hospital Inc | : 1L1RL-1 AS A CARDIOVASCULAR DISEASE MARKER |
| EP1639090A4 (en) * | 2003-06-09 | 2008-04-16 | Univ Michigan | COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER |
| US20050181451A1 (en) * | 2004-02-12 | 2005-08-18 | Bates Harold M. | Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants |
| JP2008523394A (ja) * | 2004-12-10 | 2008-07-03 | ユニヴァーシティー オブ メリーランド， バルティモア | 炎症及び肥満症における血清アミロイドａタンパク質 |
| CN2783324Y (zh) * | 2005-04-28 | 2006-05-24 | 穆海东 | 心血管疾病诊断和预测多指标蛋白芯片检测试剂盒 |
| WO2006135886A2 (en) * | 2005-06-13 | 2006-12-21 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| US20070099239A1 (en) * | 2005-06-24 | 2007-05-03 | Raymond Tabibiazar | Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease |
| US20090226420A1 (en) * | 2005-11-10 | 2009-09-10 | Elizabeth Hauser | Methods of Determining the Risk of Developing Coronary Artery Disease |
| CA2641189A1 (en) * | 2006-01-31 | 2007-08-09 | Mitsubishi Kagaku Iatron, Inc. | Method for determination of condition of disseminated intravascular coagulation syndrome |
| WO2007103568A2 (en) * | 2006-03-09 | 2007-09-13 | Biosite, Inc. | Methods and compositions for the diagnosis of diseases of the aorta |
| EP2302395B1 (en) * | 2006-06-07 | 2015-04-15 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
| EP1887361A1 (en) * | 2006-08-07 | 2008-02-13 | Bio-Rad Pasteur | Method for the prediction of vascular events |
| US7947447B2 (en) * | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| RU2376372C2 (ru) * | 2007-04-03 | 2009-12-20 | Государственное учреждение Научно-исследовательский институт медицинской генетики Томского научного центра Сибирского отделения Российской академии медицинских наук | Способ генетической диагностики подверженности к сердечно-сосудистым заболеваниям |
| EP2019318A1 (en) * | 2007-07-27 | 2009-01-28 | Erasmus University Medical Center Rotterdam | Protein markers for cardiovascular events |
| CA2693310C (en) * | 2007-08-02 | 2018-11-27 | Arresto Biosciences, Inc. | Lox and loxl2 inhibitors, antibodies and uses thereof |
| GB0717637D0 (en) * | 2007-09-10 | 2007-10-17 | Univ Leiden | Future cardiac event biomarkers |
| WO2009075566A1 (en) * | 2007-12-12 | 2009-06-18 | Erasmus University Medical Center Rotterdam | Biomarkers for cardiovascular disease |
| US20090186370A1 (en) * | 2008-01-18 | 2009-07-23 | Ogle Matthew F | Diagnostic biomarkers for vascular aneurysm |
| US8030097B2 (en) * | 2008-04-30 | 2011-10-04 | Versitech Limited and R & C Biogenius Limited | Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks |
| CA2733556A1 (en) * | 2008-08-11 | 2010-02-18 | The Board Of Regents Of The University Of Texas System | A micro-rna that promotes vascular integrity and uses thereof |
| JP5711131B2 (ja) * | 2008-10-07 | 2015-04-30 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 最初の有害事象の予測のためのバイオマーカー |
| JP5678045B2 (ja) * | 2009-06-08 | 2015-02-25 | シンギュレックス・インコーポレイテッド | 高感度バイオマーカーパネル |
| ES2623633T3 (es) * | 2009-06-09 | 2017-07-11 | Gendiag.Exe, S.L. | Marcadores de riesgo para enfermedad cardiovascular |
| JP2012529914A (ja) * | 2009-06-15 | 2012-11-29 | カーディオ ディーエクス インコーポレイティッド | 冠動脈疾患リスクの判定法 |
| US9217747B2 (en) * | 2009-10-29 | 2015-12-22 | Health Diagnostic Laboratory, Inc. | Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes |
| CN102762743A (zh) * | 2009-12-09 | 2012-10-31 | 阿维埃尔公司 | 用于心血管疾病的诊断和分类的生物标记物检验 |
| CA2808233C (en) * | 2010-03-03 | 2017-07-11 | Somalogic, Inc. | Aptamers to 4-1bb and their use in treating diseases and disorders |
| MX373248B (es) * | 2011-09-30 | 2020-05-11 | Somalogic Operating Co Inc | Prediccion de riesgo de evento cardiovascular y usos del mismo. |
| WO2013142114A1 (en) * | 2012-03-19 | 2013-09-26 | The Brigham And Women's Hosptial, Inc. | Growth differentiation factor (gdf) for treatment of diastolic heart failure |
-
2012
- 2012-09-28 MX MX2014003153A patent/MX373248B/es active IP Right Grant
- 2012-09-28 AU AU2013202112A patent/AU2013202112B9/en active Active
- 2012-09-28 EP EP12836076.5A patent/EP2761289B1/en active Active
- 2012-09-28 SG SG10201607331WA patent/SG10201607331WA/en unknown
- 2012-09-28 SG SG10201906900QA patent/SG10201906900QA/en unknown
- 2012-09-28 CA CA2847903A patent/CA2847903C/en active Active
- 2012-09-28 ES ES12836076T patent/ES2777002T3/es active Active
- 2012-09-28 KR KR1020207013434A patent/KR102248900B1/ko active Active
- 2012-09-28 WO PCT/US2012/058060 patent/WO2013049674A1/en not_active Ceased
- 2012-09-28 CN CN201280058717.0A patent/CN103959060B/zh active Active
- 2012-09-28 CA CA3074279A patent/CA3074279C/en active Active
- 2012-09-28 RU RU2014110508A patent/RU2651708C2/ru active
- 2012-09-28 CN CN201710329039.1A patent/CN107102151A/zh active Pending
- 2012-09-28 CN CN201710064624.3A patent/CN107422126B/zh active Active
- 2012-09-28 IN IN1970CHN2014 patent/IN2014CN01970A/en unknown
- 2012-09-28 JP JP2014533428A patent/JP6652781B2/ja active Active
- 2012-09-28 BR BR122019023720-4A patent/BR122019023720B1/pt active IP Right Grant
- 2012-09-28 US US13/631,567 patent/US20130085079A1/en not_active Abandoned
- 2012-09-28 SG SG11201400904SA patent/SG11201400904SA/en unknown
- 2012-09-28 KR KR1020147011813A patent/KR102111624B1/ko active Active
- 2012-09-28 CN CN202210145010.9A patent/CN114518458A/zh active Pending
- 2012-09-28 BR BR112014007214-0A patent/BR112014007214B1/pt active IP Right Grant
-
2013
- 2013-12-31 US US14/145,026 patent/US20150168423A1/en not_active Abandoned
-
2014
- 2014-03-06 IL IL231387A patent/IL231387A/en active IP Right Grant
- 2014-03-11 ZA ZA2014/01778A patent/ZA201401778B/en unknown
- 2014-03-14 MX MX2020004617A patent/MX2020004617A/es unknown
-
2018
- 2018-05-30 JP JP2018103211A patent/JP6546318B2/ja active Active
-
2019
- 2019-10-25 JP JP2019193933A patent/JP6917432B2/ja active Active
-
2020
- 2020-01-23 US US16/751,102 patent/US20200166523A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014528576A5 (https=) | ||
| Di Filippo et al. | COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: a post-hoc analysis of a prospective cohort study | |
| Cui et al. | Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock: retrospective analysis of 59 cases | |
| Wright et al. | Diagnosis of Kawasaki disease using a minimal whole-blood gene expression signature | |
| RU2014110508A (ru) | Прогнозирование риска сердечно-сосудистого события и его применение | |
| Røysland et al. | Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study | |
| Xie et al. | Biventricular longitudinal strain predict mortality in COVID-19 patients | |
| JP2017530356A5 (https=) | ||
| Demolder et al. | Association of mitral annular disjunction with cardiovascular outcomes among patients with Marfan syndrome | |
| Men et al. | Homocysteine and C-reactive protein associated with progression and prognosis of intracranial branch atheromatous disease | |
| Lin et al. | Role of the NT‑proBNP level in the diagnosis of pediatric heart failure and investigation of novel combined diagnostic criteria | |
| JP2009501318A (ja) | アテローム動脈硬化性心血管疾患の診断およびモニタリングのための方法ならびに組成物 | |
| Urata et al. | Platelet contamination causes large variation as well as overestimation of mitochondrial DNA content of peripheral blood mononuclear cells | |
| Custodis et al. | Resting heart rate is an independent predictor of all-cause mortality in the middle aged general population | |
| JP2024507978A (ja) | 脳卒中の多遺伝子性遺伝的リスクスコア及び発症リスク評価装置並びにその使用 | |
| Hendriks et al. | The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension | |
| Lambert et al. | Diagnostic accuracy of FEV1/forced vital capacity ratio z scores in asthmatic patients | |
| CN114410773A (zh) | 用于预测或诊断抑郁症复发的标志物组合及其应用 | |
| Jang et al. | Comparison of the serum creatinine-and cystatin-C–based indices as screening biomarkers for sarcopenia in community-dwelling older adults | |
| Hou et al. | Radiomics in carotid plaque: A systematic review and Radiomics quality score assessment | |
| Lyngbakken et al. | B-type natriuretic peptide is associated with indices of left ventricular dysfunction in healthy subjects from the general population: the Akershus Cardiac Examination 1950 study | |
| Van Hattum et al. | ELITE: rationale and design of a longitudinal elite athlete, extreme cardiovascular phenotyping, prospective cohort study | |
| Stępnowska et al. | Prognostic factors in pulmonary arterial hypertension: Literature review. | |
| Vorn et al. | Are EPB41 and alpha-synuclein diagnostic biomarkers of sport-related concussion? Findings from the NCAA and Department of Defense CARE Consortium | |
| RU2618443C1 (ru) | Способ прогнозирования риска развития атеросклеротических изменений сосудов у европеоидов |